Clinical trials: Acne Vulgaris Superficial Mixed Comedonal and Inflammatory
Acne Vulgaris, Acne Vulgaris Superficial Mixed Comedonal and Inflammatory
Full Spectrum Hemp Observational Study
In westernized societies, acne vulgaris is nearly a universal skin disease afflicting 79% to 95% of the adolescent population; older than 25 years - 40% to 54% have facial blemishes and persists into middle age in 12% of women…
- Trial name
- NCT04730414
- Testing
- Full-spectrum hemp (0.018% THC)
- Volunteers
- 50 people
- Sponsor
- Charlotte's Web, Inc
Acne Vulgaris Superficial Mixed Comedonal and Inflammatory
Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne Vulgaris
From the obtained results, topical Flutamide 1% gel can be a promising, effective, and safe alternative in treating patients with acne vulgaris with minimal side effects.
- Trial name
- NCT05478330
- Testing
- Flutamide 1% gel, topical gel without flutamide
- Where
- Egypt
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Zagazig University
Acne Vulgaris Superficial Mixed Comedonal and Inflammatory
Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne
Acne vulgaris is a complex skin disorder involving multiple abnormalities of the pilosebaceous unit. Acne is the most common skin disease during puberty and worsens throughout adolescence.
- Trial name
- NCT03076320
- Testing
- PDF+M-DDO, A+PBO
- Where
- Mexico
- Volunteers
- 82 people
- Sponsor
- University of Guadalajara